Snowball logo
logo
LBLT_logo

Lattice Biologics Ltd

LBLTF • PINK
$0.0001$0.00  (0%)
Estimate
EPS
-0.01
Beta
0.925
About the company
Ticker
LBLTF
ISIN
Country
United States of America
Sector (GICS)
Healthcare
Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization, and regeneration The company also develops amniotic fluid-based products, such as AmnioBoost and AmnioBlast. In addition, it sells traditional allografts for multi-disciplinary applications, including orthopedics, neurology, podiatry, and oral/maxillofacial. The company is headquartered in Belgrade, Montana.

Frequently asked questions

What sector does Lattice Biologics Ltd (LBLTF) operate in?

Lattice Biologics Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Lattice Biologics Ltd (LBLTF) current stock price?

As of the latest data, Lattice Biologics Ltd stock price is $0.00, with a previous close of $0.00.

What is Lattice Biologics Ltd (LBLTF) current market capitalization?

Lattice Biologics Ltd market cap is approximately 12.82 thousand.

What is Lattice Biologics Ltd (LBLTF) Earnings Per Share (EPS)?

The trailing EPS is -$0.01.

Does Lattice Biologics Ltd (LBLTF) pay dividends?

No. Lattice Biologics Ltd does not pay a dividend.

What is Lattice Biologics Ltd (LBLTF) beta (volatility) score?

Lattice Biologics Ltd has a beta of 0.925, meaning its volatility is roughly in line with the market.